Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 12/20 | 0.37 |
| ▸ | CREBBP | Q92793 | 7/20 | 0.37 |
| ▸ | BRD2 | P25440 | 6/20 | 0.37 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.35 |
| ▸ | FFAR2 | O15552 | 3/20 | 0.33 |
| ▸ | ATAD2 | Q6PL18 | 1/20 | 0.32 |
| ▸ | ERN1 | O75460 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL314839 | 1.00 | BRD4 (0.37) | BRD4CREBBPBRD2FFAR1FFAR2 | |
| SCHEMBL2415822 | 0.87 | BRD4 (0.46) | BRD4CREBBPBRD2FFAR1FFAR2 | |
| SCHEMBL2415825 | 0.87 | BRD4 (0.46) | BRD4CREBBPBRD2FFAR1FFAR2 | |
| SCHEMBL313969 | 0.84 | CYP11B2 (0.31) | — | |
| SCHEMBL3399026 | 0.84 | CYP11B2 (0.31) | — | |
| SCHEMBL315935 | 0.83 | FFAR1 (0.33) | BRD4CREBBPBRD2FFAR1 | |
| SCHEMBL315936 | 0.83 | FFAR1 (0.33) | BRD4CREBBPBRD2FFAR1 | |
| SCHEMBL315640 | 0.83 | PIK3CG (0.32) | — | |
| SCHEMBL3400268 | 0.83 | PIK3CG (0.32) | — | |
| SCHEMBL315701 | 0.83 | MKNK1 (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2066683-B1 | DERIVATIVES OF 5-THIOXYLOPYRANOSE AND USE OF SAME FOR TREATMENT | FOURNIER LAB SA (FR) | 2010-11-03 | — | — | EP | disclosed |